This study demonstrated the effect of BMSCs on the K562 cell as a CML cell line by investigating telomere length, telomerase activity, and hTERT gene expression through P53, Wnt5a and β-catenin signaling pathways. The gene discussed is TP53; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.